126 related articles for article (PubMed ID: 18627469)
1. Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates.
Basma R; Barada G; Ojaimi N; Khalaf RA
Mycoses; 2009 Mar; 52(2):141-8. PubMed ID: 18627469
[TBL] [Abstract][Full Text] [Related]
2. Fluconazole induces rapid high-frequency MTL homozygosis with microbiological polymorphism in Candida albicans.
Ou TY; Chang FM; Cheng WN; Lara A; Chou ML; Lee WF; Lee KC; Lin CT; Lee WS; Yu FL; Su CH
J Microbiol Immunol Infect; 2017 Dec; 50(6):899-904. PubMed ID: 26928371
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
4. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
5. Mating genotypes and susceptibility profiles of clinical isolates of Candida glabrata from Turkey.
Kaplan E; Aktaş D; Önder Ş; Metin B; Döğen A; Oz Y; Ilkit M
Mycoses; 2019 Sep; 62(9):796-802. PubMed ID: 31134666
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Araj GF; Daher NK; Tabbarah ZA
Int J Antimicrob Agents; 1998 Nov; 10(4):291-6. PubMed ID: 9916903
[TBL] [Abstract][Full Text] [Related]
7. Homozygosity at the Candida albicans MTL locus associated with azole resistance.
Rustad TR; Stevens DA; Pfaller MA; White TC
Microbiology (Reading); 2002 Apr; 148(Pt 4):1061-1072. PubMed ID: 11932451
[TBL] [Abstract][Full Text] [Related]
8. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
[TBL] [Abstract][Full Text] [Related]
9. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
[TBL] [Abstract][Full Text] [Related]
10. Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
Soler L; Rodriguez JC; Belda S; Cremades R; Ruiz-Garcia M; Lopez P; Royo G
J Chemother; 2010 Aug; 22(4):283-4. PubMed ID: 20685636
[No Abstract] [Full Text] [Related]
11. In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1.
Odds FC
FEMS Yeast Res; 2009 Oct; 9(7):1091-101. PubMed ID: 19799637
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
Toutounji M; Tokajian S; Khalaf RA
Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
[TBL] [Abstract][Full Text] [Related]
14. Azole-resistant Candida albicans from a wild Brazilian porcupine (Coendou prehensilis): a sign of an environmental imbalance?
Castelo-Branco DS; Brilhante RS; Paiva MA; Teixeira CE; Caetano EP; Ribeiro JF; Cordeiro RA; Sidrim JJ; Monteiro AJ; Rocha MF
Med Mycol; 2013 Jul; 51(5):555-60. PubMed ID: 23286353
[TBL] [Abstract][Full Text] [Related]
15. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance is not directly affected by mating type locus zygosity in Candida albicans.
Pujol C; Messer SA; Pfaller M; Soll DR
Antimicrob Agents Chemother; 2003 Apr; 47(4):1207-12. PubMed ID: 12654648
[TBL] [Abstract][Full Text] [Related]
17. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
[TBL] [Abstract][Full Text] [Related]
19. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
Jensen RH; Astvad KM; Silva LV; Sanglard D; Jørgensen R; Nielsen KF; Mathiasen EG; Doroudian G; Perlin DS; Arendrup MC
J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
[TBL] [Abstract][Full Text] [Related]
20. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.
Manoharlal R; Gorantala J; Sharma M; Sanglard D; Prasad R
Microbiology (Reading); 2010 Feb; 156(Pt 2):313-326. PubMed ID: 19910410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
